<DOC>
	<DOCNO>NCT01571193</DOCNO>
	<brief_summary>In present study , investigator examine determine whether pomegranate extract benefit cognitive ability middle-aged old non-demented volunteer . More specifically , investigator test follow primary hypothesis : 1 . Non-demented volunteer age 50-75 receive daily dietary supplement pomegranate extract show improve cognitive performance compare baseline versus receive placebo one , six , twelve month . The investigator also explore follow secondary hypothesis : 2 . Cognitive change pomegranate intervention group vary accord genotype find influence age-related cognitive decline ( i.e. , apolipoprotein E [ APOE ] ) .</brief_summary>
	<brief_title>Twelve-Month Study Pomegranate Extract Normal Aging</brief_title>
	<detailed_description>To test primary hypothesis , 212 non-demented subject enrol . Subjects randomize , use double-blind design , one two treatment group : supplement ( 1,000 mg pomegranate extract per day ) placebo , follow 12 month . Neuropsychological assessment determine cognitive change , repeat 1 , 6 12 month . All subject receive baseline assessment ( clinical examination , MRI scan , screen laboratory test ) order exclude volunteer dementia condition might influence result . We draw additional blood freeze possible later assessment inflammatory measure explore whether pomegranate extract effect measure inflammation . These sample analyze find extract show cognitive benefit .</detailed_description>
	<criteria>Agreement participate 12month doubleblind , placebocontrolled clinical trial pomegranate extract . Nondemented subject either normal cognition amnestic Mild Cognitive Impairment include . Age 50 75 year . No significant cerebrovascular disease : modify Ischemic Score &lt; 4 ( Rosen et al , 1980 ) . Adequate visual auditory acuity allow neuropsychological testing . Screening laboratory test EKG without significant abnormality might interfere study . Diagnosis probable Alzheimer 's disease ( AD ) dementia ( e.g. , vascular , Lewy body , frontotemporal ) ( McKhann et al , 1984 ) . Evidence neurological physical illness produce cognitive deterioration . Volunteers history stroke , TIA , carotid bruits , lacunes MRI scan exclude . Determination dementia base clinical evaluation include assessment functional ability , cognitive screening . Contraindication MRI include claustrophobia , metal body , surgery within 60 day , certain implant previous abnormal MRI result . Evidence Parkinson 's disease determine motor examination ( item 1831 ) Unified Parkinson 's Disease Rating Scale ( Fahn et al , 1987 ) . History myocardial infarction within previous year , unstable cardiac disease . Uncontrolled hypertension ( systolic BP &gt; 170 diastolic BP &gt; 100 ) . History significant liver disease , clinicallysignificant pulmonary disease , diabetes , cancer . Current diagnosis major psychiatric disorder accord DSMIV TR criterion ( APA , 2000 ) . Current diagnosis history alcoholism substance addiction . Regular use medication may affect cognitive function include : centrally active betablockers , narcotic , Clonidine , antiParkinsonian medication , antipsychotic , benzodiazepine , systemic corticosteroid , medication significant cholinergic anticholinergic effect , anticonvulsant , Warfarin . Occasional chloral hydrate use allow , discourage , insomnia . Use one multivitamin per day . Vitamins standard multivitamin supplement allow . Use cognitive enhancing supplement ( e.g . Ginkgo biloba ) . Use medication metabolize 2C9 include : fluconazole , amiodarone , fenofibrate , fluvastatin , fluvoxamine , isoniazid , lovastatin , phenylbutazone , probenecid , sertraline , sulfamethoxazole , sulfaphenazole teniposide , voriconazole , zafirlukast . Use one daily baby aspirin ( 81mg ) and/or use supplement contain pomegranate . Use investigational drug within previous month longer , depend drug halflife . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>